Prof Roland Stocker awarded 2021 Basic Science Award
Professor Roland Stocker, leader of the Arterial Inflammation and Redox Biology Group at HRI, has been awarded the 2021 Basic Science Award from the esteemed Society for Free Radical Research-Europe.
New hope for babies born with heart defect
Dr Ashish Misra is conducting research that opens a pathway towards a improved therapy for patients with the heart defect SVAS.
First congenital heart disease registry launched in Australia
In an Australian first, doctors have developed the Australian New Zealand Congenital Heart Disease Registry to help improve the lives of people living with the condition, and their families.
Six significant grants to solve the UK’s biggest killer – cardiovascular disease
HRI is delighted to announce the award of six grants funded by HRI UK donors to support research into cardiovascular disease – the world’s biggest killer.
A pioneering generation: people with complex congenital heart disease living longer
People born with half a heart or single-ventricle congenital heart disease (Fontan-CHD) are now living longer than ever before, thanks to advances in medicine and technology.
Arterial Inflammation and Redox Biology Group publishes in Nature Communications
The Arterial Inflammation and Redox Biology Group, led by Professor Roland Stocker, has published a paper in the prestigious Nature Communications journal.
HRI wins Silver in PRIA Golden Target Awards
A fundraising appeal by the Heart Research Institute (HRI) has won silver in the Golden Target Awards, run by the Public Relations Institute of Australia (PRIA).
Dr Xuyu Liu awarded cardiovascular drug discovery grant
Congratulations to Dr Xuyu Liu on being awarded a Drug Discovery Initiative and Cardiovascular Initiative Partnership Grant for his research “A PROTAC-based bioengineering platform for more efficacious antiplatelet drug discovery”.
Quadruple success for HRI
HRI researchers have been awarded an outstanding four grants under the NSW Cardiovascular Research Capacity Program.